Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-29T02:05:36.409Z Has data issue: false hasContentIssue false

Laryngeal biopsies: are we doing more, and why? A decade of results

Published online by Cambridge University Press:  08 December 2015

S Lim*
Affiliation:
Department of Otolaryngology Head and Neck Surgery, University of Glasgow, Scotland, UK
P Sau
Affiliation:
Department of Medical School, University of Glasgow, Scotland, UK
L Cooper
Affiliation:
Department of Pathology, Glasgow Royal Infirmary, University of Glasgow, Scotland, UK
A McPhaden
Affiliation:
Department of Pathology, Glasgow Royal Infirmary, University of Glasgow, Scotland, UK
K MacKenzie
Affiliation:
Department of Otolaryngology Head and Neck Surgery, University of Glasgow, Scotland, UK
*
Address for correspondence: Dr Shueh Lim, Department of Otolaryngology Head and Neck Surgery, Glasgow Royal Infirmary, 84 Castle Street, Glasgow G4 0SF, Scotland, UK Fax: 0141 211 4999 E-mail: [email protected]

Abstract

Background:

Over the last decade, we have observed an escalating trend in the number of laryngeal biopsies performed, despite the incidence of laryngeal cancer remaining constant. This study aimed to quantify the rate of laryngeal biopsies and record the indications.

Method:

A retrospective analysis of laryngeal biopsies performed in North Glasgow, Scotland, UK, between 2001 and 2010, was conducted.

Results:

From 2001 to 2010, 3902 laryngeal biopsies were carried out in North Glasgow. Histopathological results indicated the following diagnoses: squamous cell carcinoma, in 889 cases (23 per cent); dysplasia, in 986 cases (25 per cent); ‘no tumour’, in 913 cases (23 per cent); and benign pathology, in the remaining 1084 cases (28 per cent). There has been a significant increase in the number of biopsies performed after 2004, with the incidence of squamous cell carcinoma and benign disease remaining relatively static.

Conclusion:

It is hypothesised that organ preservation strategies, endoscopic resection in early stage laryngeal cancer and chemoradiotherapy in advanced head and neck cancer are responsible for the increase in laryngeal biopsies.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Presented at the American Academy of Otolaryngology – Head and Neck Surgery Annual Meeting, 9–12 September 2012, Washington, DC, USA, the Laryngology and Rhinology Section Meeting, Royal Society of Medicine, 2 March 2012, London, UK, and the ENT Scotland Meeting, 13 May 2011, Dunblane, Scotland, UK.

References

1General Register Office for Scotland. In: http://www.gro-scotland.gov.uk [1 October 2015]Google Scholar
2Information Services Division Scotland. Cancer Statistics: Head and Neck Cancer. In: http://www.isdscotland.org/health-topics/cancer/cancer-statistics/head-and-neck [1 October 2015]Google Scholar
3Forastiere, A, Goepfert, H, Maor, M, Pajak, TF, Weber, R, Morrison, W et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091–8CrossRefGoogle ScholarPubMed
4Mehanna, H, Paleri, V, Robson, A, Wight, R, Helliwell, T. Consensus statement by otorhinolaryngologists and pathologists on the diagnosis and management of laryngeal dysplasia. Clin Otolaryngol 2010;35:170–6CrossRefGoogle ScholarPubMed